MedPlus Health Services Limited

₹612.35As of Sun 8 Nov 2026, 12:00 UTC
NSE:MEDPLUSHealthcare
Country India
PE (Fwd) •••
TSR 5Y CAGR (10.29%)
Div yield —
ROE 10.79%
Pharmaceutical Retailers
Beta (5Y) 0.50
PE TTM 34.74
TSR TTM (19.73%)
Mkt cap ₹73.56B
ROIC 9.19%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹657
7.24%
(64.64%)
Hold 5|5|10|2|1
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
10.06
9.89
9.93
10.28
18.56%
16.65%
5.45%
4.19%
Revenue₹B
4.432
4.548
4.645
4.797
8.15%
12.94%
11.36%
13.44%
Peers (US$770.4M)
Cap (US$)
PE
644.0M
46.60x
629.6M
27.41x
828.1M
22.01x
Capital
TTM
5Y
10Y
Leveragex
0.851
(0.021)
(0.020)
EBIT/Intx
0.797
0.073
0.081
Own earn%
(363.57)
37.08
43.28
Sh yield%
43.12
23.97
25.90
Owners
Insiders/Inst%
13.66
49.93
Short interest%
2.19
SBC / revenue%
3.39
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
14–21
$1 testx
0.2
Incr. ROIC%
15